C11ORF82 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.970600E-01
Normal-vs-Stage2
9.762400E-01
Normal-vs-Stage3
4.975600E-01
Normal-vs-Stage4
9.326000E-01
Stage1-vs-Stage2
6.924800E-01
Stage1-vs-Stage3
5.109600E-01
Stage1-vs-Stage4
8.501200E-01
Stage2-vs-Stage3
3.471200E-01
Stage2-vs-Stage4
9.120000E-01
Stage3-vs-Stage4
4.552200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.874600E-01
Normal-vs-AfricanAmerican
8.222800E-01
Normal-vs-Asian
6.422200E-01
Caucasian-vs-AfricanAmerican
6.482200E-01
Caucasian-vs-Asian
5.845600E-01
AfricanAmerican-vs-Asian
5.206200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.686200E-01
Normal-vs-Female
9.927800E-01
Male-vs-Female
2.989600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.586200E-01
Normal-vs-Age(41-60Yrs)
9.700200E-01
Normal-vs-Age(61-80Yrs)
7.822600E-01
Normal-vs-Age(81-100Yrs)
8.275000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.290400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.097600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.126600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.505800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.968200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.413600E-01
Normal-vs-Daily Drinker
8.939000E-01
Normal-vs-Weekly Drinker
8.249800E-01
Normal-vs-Occasional Drinker
8.890400E-01
Normal-vs-Social Drinker
9.874600E-01
Non Drinker-vs-Daily Drinker
6.792800E-01
Non Drinker-vs-Weekly Drinker
3.835200E-01
Non Drinker-vs-Occasional Drinker
6.130800E-01
Non Drinker-vs-Social Drinker
4.119000E-01
Daily Drinker-vs-Weekly Drinker
5.337200E-01
Daily Drinker-vs-Occasional Drinker
9.820400E-01
Daily Drinker-vs-Social Drinker
8.080800E-01
Weekly Drinker-vs-Occasional Drinker
5.374200E-01
Weekly Drinker-vs-Social Drinker
6.324600E-01
Occasional Drinker-vs-Social Drinker
8.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.575800E-01
Normal-vs-Grade 2
6.113600E-01
Normal-vs-Grade 3
6.462200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.858650E-03
Grade 1-vs-Grade 3
1.66151999999586E-05
Grade 1-vs-Grade 4
5.575800E-01
Grade 2-vs-Grade 3
4.876000E-02
Grade 2-vs-Grade 4
6.113600E-01
Grade 3-vs-Grade 4
6.462200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.633000E-01
Normal-vs-NonDiabetic
8.918600E-01
Diabetic-vs-NonDiabetic
6.569600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.076400E-01
Normal-vs-NoPancreatitis
8.257800E-01
Pancreatitis-vs-NoPancreatitis
3.005400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.075000E-01
Normal-vs-N1
9.546200E-01
N0-vs-N1
5.889200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.622600E-01
Normal-vs-TP53-NonMutant
7.556000E-01
TP53-Mutant-vs-TP53-NonMutant
2.10669999999302E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
